In the present study, CEBPB was found to enhance the secretion and expression of inflammatory cytokines (TNF-α, IL-6, and IL-1β), exacerbate AOM/DSS-induced pathological loss of colon tissue, and upregulate the expression of oncogenes. This evidence concerns the gene IL1B and infectious otitis media.